Tahani H Nageeti, Umme Salma, Duaa A Alhawi, Omar Kalantan Kalantan, Elham Rashaidi, Nesreen M Shorbagi
{"title":"ESTRO-ACROP guidelines in postmastectomy radiation after immediate reconstruction: Dosimetric Comparison of 3D-CRT versus VMAT planning.","authors":"Tahani H Nageeti, Umme Salma, Duaa A Alhawi, Omar Kalantan Kalantan, Elham Rashaidi, Nesreen M Shorbagi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate target volume coverage and organs at risk (OARs) sparing comparing 3D-Conformal Radiation (3D-CRT) vs. Volumetric Arc Treatme nt (VMAT) planning based on contouring guidelines of European Society for Therapeutic Radiology and Oncology Advisory Committee in Radiation Oncology Practice (ESTRO-ACROP) for implant sparing and target volume delineation in postmastectomy radiation therapy (PMRT) after immediate breast reconstruction (IBR).</p><p><strong>Materials and methods: </strong>Ten eligible patients were identified via a retrospective chart review. The CTsimulation scans were used to contour target volumes applying ESTRO-ACROP guidelines and OARs. For each case, 3D-CRT and VMAT plans were generated to evaluate the best achievement of target volume coverage and minimal dose to OARs.</p><p><strong>Results: </strong>There was a significant difference towards VMAT for PTV coverage by 90% and 95% isodose line. The VMAT, compared to 3D-CRT, showed a lower mean (PTV-105%) (8.1 vs. 17.8), (p-value 0.000034). The OARs sparing showed a significant difference in favor of VMAT for ipsilateral lateral lung V20 (p-value 0.007048), both lungs' mean dose (p-value 0.019021), and heart mean dose (p-value 0.000076). The 3D-CRT plan showed lower thyroid mean dose (19.27 vs 23cc), (p-value 0.0235), and contralateral breast Dmax, D5 and D10, p-values (0.04088, < 0.00001 and < 0.00001), respectively. In the implant doses, there was no statistical difference between Dmax (54.59Gy vs. 54.14Gy), while there was a statistically significantly lower mean implant dose for VMAT (43.83Gy) vs. 3D-CRT (50.81Gy), (p-value < 0.00001).</p><p><strong>Conclusion: </strong>Our study showed an advantage of VMAT compared to 3D-CRT following ESTRO-ACROP consensus for implant sparing in PMRT.</p>","PeriodicalId":53633,"journal":{"name":"The gulf journal of oncology","volume":"1 47","pages":"79-82"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The gulf journal of oncology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To evaluate target volume coverage and organs at risk (OARs) sparing comparing 3D-Conformal Radiation (3D-CRT) vs. Volumetric Arc Treatme nt (VMAT) planning based on contouring guidelines of European Society for Therapeutic Radiology and Oncology Advisory Committee in Radiation Oncology Practice (ESTRO-ACROP) for implant sparing and target volume delineation in postmastectomy radiation therapy (PMRT) after immediate breast reconstruction (IBR).
Materials and methods: Ten eligible patients were identified via a retrospective chart review. The CTsimulation scans were used to contour target volumes applying ESTRO-ACROP guidelines and OARs. For each case, 3D-CRT and VMAT plans were generated to evaluate the best achievement of target volume coverage and minimal dose to OARs.
Results: There was a significant difference towards VMAT for PTV coverage by 90% and 95% isodose line. The VMAT, compared to 3D-CRT, showed a lower mean (PTV-105%) (8.1 vs. 17.8), (p-value 0.000034). The OARs sparing showed a significant difference in favor of VMAT for ipsilateral lateral lung V20 (p-value 0.007048), both lungs' mean dose (p-value 0.019021), and heart mean dose (p-value 0.000076). The 3D-CRT plan showed lower thyroid mean dose (19.27 vs 23cc), (p-value 0.0235), and contralateral breast Dmax, D5 and D10, p-values (0.04088, < 0.00001 and < 0.00001), respectively. In the implant doses, there was no statistical difference between Dmax (54.59Gy vs. 54.14Gy), while there was a statistically significantly lower mean implant dose for VMAT (43.83Gy) vs. 3D-CRT (50.81Gy), (p-value < 0.00001).
Conclusion: Our study showed an advantage of VMAT compared to 3D-CRT following ESTRO-ACROP consensus for implant sparing in PMRT.
目的:根据欧洲放射肿瘤学治疗和肿瘤咨询委员会放射肿瘤学实践(ESTRO-ACROP)的轮廓指导方针,评估乳房切除术后放疗(PMRT)即刻乳房重建(IBR)后植入物保留和靶体积划定,比较3d适形放疗(3D-CRT)和体积弧形治疗(VMAT)计划的靶体积覆盖和危险器官(OARs)保留。材料和方法:通过回顾性图表分析确定10例符合条件的患者。ct模拟扫描使用ESTRO-ACROP指南和桨来轮廓靶体。对于每个病例,生成3D-CRT和VMAT计划,以评估目标体积覆盖的最佳实现和对OARs的最小剂量。结果:VMAT的PTV覆盖率为90%和95%等剂量线有显著差异。与3D-CRT相比,VMAT显示较低的平均值(PTV-105%) (8.1 vs. 17.8), (p值0.000034)。OARs显示VMAT在同侧侧肺V20 (p值0.007048)、双肺平均剂量(p值0.019021)和心脏平均剂量(p值0.000076)上具有显著差异。3D-CRT方案显示甲状腺平均剂量较低(19.27 vs 23cc) (p值0.0235),对侧乳腺Dmax、D5、D10 p值分别为0.04088、< 0.00001、< 0.00001)。在种植体剂量方面,Dmax组(54.59Gy vs. 54.14Gy)无统计学差异,VMAT组(43.83Gy)比3D-CRT组(50.81Gy)平均种植体剂量低,差异有统计学意义(p值< 0.00001)。结论:我们的研究显示VMAT与3D-CRT相比具有ESTRO-ACROP共识的PMRT种植体保留优势。